Cytovene and Solu-medrol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cytovene (ganciclovir) and Solu-medrol (methylprednisolone sodium succinate). Common drug interactions include pain of skin among females and drug toxicity among males.

The phase IV clinical study analyzes what interactions people have when they take Cytovene and Solu-medrol. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Cytovene?

Cytovene has active ingredients of ganciclovir. eHealthMe is studying from 419 Cytovene users. Check the latest studies of Cytovene.

What is Solu-medrol?

Solu-medrol has active ingredients of methylprednisolone sodium succinate. It is often used in multiple sclerosis. eHealthMe is studying from 39,410 Solu-medrol users. Check the latest studies of Solu-medrol.



On Aug, 01, 2026

37 people who take Cytovene and Solu-medrol together, and have interactions are studied.

Cytovene and Solu-medrol drug interactions.

What are the common drug interactions of Cytovene and Solu-Medrol, by gender? *:

female:

  1. Pain of skin
  2. Blood creatinine increased
  3. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  4. Klebsiella infection
  5. Renal failure acute (rapid kidney dysfunction)
  6. Activated partial thromboplastin time prolonged
  7. Blood fibrinogen increased
  8. Blood pressure diastolic decreased
  9. Cardiovascular disorder (heart diseases)
  10. Coagulation factor viii level increased

male:

  1. Drug toxicity
  2. Anaemia (lack of blood)
  3. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  4. Diarrhoea
  5. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  6. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
  7. Apnoea (suspension of external breathing)
  8. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  9. Cytomegalovirus infection
  10. Fatigue (feeling of tiredness)

What are the common drug interactions of Cytovene and Solu-Medrol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Apnoea (suspension of external breathing)
  2. Intracranial pressure increased (high pressure inside the skull and thus in the brain tissue and cerebrospinal fluid)
  3. Headache (pain in head)
  4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  5. Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  6. Carotid artery stenosis (narrowing of carotid artery)
  7. Haemorrhage intracranial (bleeding within the skull)
  8. Heart transplant rejection
  9. Brain herniation (brain herniation is a potentially deadly side effect of very high intracranial pressure that occurs when a part of the brain is squeezed across structures within the skull)
  10. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)

20-29:

  1. Cardiac tamponade (fluid accumulates in heart covering)
  2. Pericardial effusion (fluid around the heart)
  3. Sepsis (a severe blood infection that can lead to organ failure and death)
  4. Cardiac arrest
  5. Drug toxicity
  6. Viral infection
  7. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  8. Diarrhoea
  9. Hypotension (abnormally low blood pressure)
  10. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)

30-39:

  1. Cerebral disorder (brain disease)
  2. Cerebral infarction (less blood supply to brain resulting tissue damage)
  3. Delirium (wild excitement)
  4. Pulmonary hypertension (increase in blood pressure in the lung artery)
  5. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  6. Coma (state of unconsciousness lasting more than six hours)
  7. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  8. Hypertension (high blood pressure)
  9. Pulmonary embolism (blockage of the main artery of the lung)
  10. Activated partial thromboplastin time prolonged

40-49:

  1. Drug toxicity
  2. Dyspnoea (difficult or laboured respiration)
  3. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  4. Haemoglobin decreased
  5. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  6. Protein total decreased
  7. Red blood cell count decreased
  8. Renal failure acute (rapid kidney dysfunction)
  9. Thromboembolism (obstruction of artery by blood clot)
  10. Alanine aminotransferase increased

50-59:

  1. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  2. Klebsiella infection
  3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  4. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  5. Blood chloride decreased
  6. Dehydration (dryness resulting from the removal of water)
  7. Fluid overload (too much fluid in the blood)
  8. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  9. Headache (pain in head)
  10. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)

60+:

  1. Bacteraemia (presence of bacteria in the blood)
  2. Renal failure acute (rapid kidney dysfunction)
  3. Confusion
  4. Depression
  5. Electrocardiogram qt prolonged
  6. Extrasystoles
  7. Face oedema (swelling of face)
  8. Feeling cold
  9. Gastric ulcer haemorrhage (bleeding ulcer of stomach)
  10. Gastrointestinal infection (infection of stomach and intestine)

What are the existing conditions these people have? *

  1. Unevaluable Reaction: 3 people, 8.11%
  2. Immunodeficiency Disorders: 2 people, 5.41%
  3. Acute Myeloid Leukaemia Recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent): 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Cytovene and Solu-medrol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cytovene and Solu-medrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cytovene:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Solu-medrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cytovene and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Solu-medrol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ganciclovir and methylprednisolone sodium succinate (the active ingredients of Cytovene and Solu-medrol, respectively), and Cytovene and Solu-medrol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: